Three-dimensional structure of kappa-conotoxin PVIIA, a novel potassium channel-blocking toxin from cone snails

Biochemistry
P SavarinAndré Ménez

Abstract

kappa-Conotoxin PVIIA from the venom of Conus purpurascens is the first cone snail toxin that was described to block potassium channels. We synthesized chemically this toxin and showed that its disulfide bridge pattern is similar to those of omega- and delta-conotoxins. kappa-conotoxin competes with radioactive alpha-dendrotoxin for binding to rat brain synaptosomes, confirming its capacity to bind to potassium channels; however, it behaves as a weak competitor. The three-dimensional structure of kappa-conotoxin PVIIA, as elucidated by NMR spectroscopy and molecular modeling, comprises two large parallel loops stabilized by a triple-stranded antiparallel beta-sheet and three disulfide bridges. The overall fold of kappa-conotoxin is similar to that of calcium channel-blocking omega-conotoxins but differs from those of potassium channel-blocking toxins from sea anemones, scorpions, and snakes. Local topographies of kappa-conotoxin PVIIA that might account for its capacity to recognize Kv1-type potassium channels are discussed.

References

Nov 1, 1992·Journal of Biomolecular NMR·M PiottoV Sklenár
May 4, 1987·European Journal of Biochemistry·S G HybertsG Wagner
Jan 1, 1994·Annual Review of Biochemistry·B M OliveraM E Adams
Nov 20, 1993·Journal of Molecular Biology·P K PallaghyR S Norton
Jan 1, 1993·Medicinal Research Reviews·A L Harvey
Jun 1, 1996·Journal of Bioenergetics and Biomembranes·J O Dolly, D N Parcej
Dec 1, 1996·Journal of Biomolecular NMR·R A LaskowskiJ M Thornton
Jan 1, 1997·General Pharmacology·A L Harvey

❮ Previous
Next ❯

Citations

Mar 18, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Abel Aneiros, Anoland Garateix
Aug 2, 2003·Toxicon : Official Journal of the International Society on Toxinology·Silke KaufersteinDietrich Mebs
Oct 29, 1998·Toxicon : Official Journal of the International Society on Toxinology·A Ménez
Feb 11, 2000·Toxicon : Official Journal of the International Society on Toxinology·A C FontanaJ Coutinho-Netto
Jul 10, 1999·The Journal of General Physiology·H TerlauF Conti
Aug 25, 2006·Acta Crystallographica. Section D, Biological Crystallography·Catherine Y DyMartin P Horvath
Dec 19, 2014·Marine Drugs·Samuel D Robinson, Raymond S Norton
Jan 3, 2016·Toxicon : Official Journal of the International Society on Toxinology·Steve PeigneurKazuki Sato
Jan 7, 2005·Journal of Peptide Science : an Official Publication of the European Peptide Society·Stephanie MouhatJean-Marc Sabatier
May 20, 2003·The European Journal of Neuroscience·Isabelle Huys, Jan Tytgat
Jun 26, 2003·Protein Science : a Publication of the Protein Society·Pierre EscoubasHervé Darbon
Jun 23, 2004·Toxicon : Official Journal of the International Society on Toxinology·Besma JouirouJean-Marc Sabatier
Sep 6, 2006·Toxicon : Official Journal of the International Society on Toxinology·Raymond S Norton, Baldomero M Olivera
Feb 14, 2006·Pharmacology & Therapeutics·Susan I V Judge, Christopher T Bever
Jun 4, 2013·Toxicon : Official Journal of the International Society on Toxinology·Steve PeigneurKazuki Sato
May 25, 2015·Asian Pacific Journal of Tropical Medicine·Palanisamy Satheesh KumarSundaresan Umamaheswari
Apr 14, 2012·Toxicon : Official Journal of the International Society on Toxinology·Joycelyn B S ChunJon-Paul Bingham
Feb 1, 2003·FEBS Letters·Alessandro Grottesi, Mark S P Sansom
May 23, 2002·Biophysical Journal·David Naranjo
Apr 20, 2016·Biotechnology and Bioengineering·Soohyun KwonDavid J Craik
Aug 24, 2002·The Journal of Biological Chemistry·Luke A MilesRaymond S Norton
Mar 13, 2012·Pharmacological Reviews·Richard J LewisMacDonald J Christie
Feb 16, 2016·Biochemistry. Biokhimii︠a︡·A I KuzmenkovA A Vassilevski
May 20, 2000·The Journal of Biological Chemistry·R B JacobsenH Terlau
Aug 31, 2013·Biomedit︠s︡inskai︠a︡ khimii︠a︡·A É FedosovB M Olivera
Dec 12, 2014·Intrinsically Disordered Proteins·Linder C DaSilvaCollin M Stultz
Jan 13, 2004·Physiological Reviews·Heinrich Terlau, Baldomero M Olivera
Apr 1, 2005·The Journal of Biological Chemistry·Laurent VerdierTeresa Carlomagno
Oct 17, 2003·The Journal of Biological Chemistry·Isabelle HuysJan Tytgat
Feb 7, 2016·The Journal of Biological Chemistry·Virginia M BurgerCollin M Stultz
Jul 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fu-Ying DaoHao Lin
Apr 5, 2020·Marine Drugs·Rocio K Finol-UrdanetaAhmed Al-Sabi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.